Open AccessAbstract 3650: Integrative mass spectrometry and RNA-sequencing identifies DLK1 as a candidate immunotherapeutic target in neuroblastoma
Author(s) -
Amber K. Weiner,
Alexander B. Radaoui,
Nathan M. Kendsersky,
Jo Lynne Harenza-Rokita,
Simone Sidoli,
Karina L. Conkrite,
Zalman Vaksman,
Komal S. Rathi,
Pichai Raman,
Daniel Martı́nez,
Tricia R. Bhatti,
Matthew Tsang,
Bruce Pawel,
Benjamin A. Garcia,
John M. Maris,
Sharon J. Diskin
Publication year - 2019
Publication title -
tumor biology
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1423-0380
pISSN - 1010-4283
DOI - 10.1158/1538-7445.sabcs18-3650
Subject(s) - mass spectrometry , computational biology , neuroblastoma , rna , computer science , chemistry , biology , chromatography , genetics , gene , biochemistry , cell culture